Clinical Trial Update: Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluates the success rate and color stability of Mineral Trioxide Aggregate pulpotomies in primary molars.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulpitis
• Reversible Pulpitis

Drugs mentioned

• Mineral Trioxide Aggregate (MTA) (Mineral Trioxide Aggregate)

Snippet

Sponsor: Texas A & M University Baylor College Of Dentistry | Conditions: Reversible Pulpitis, Dental Pulp Diseases | Phase 4 | Status: UNKNOWN